Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

We anticipate Livanova can bring leverage down to the target range by 2027, which would put the firm's debt at levels typical of medtech firms. Interest coverage remains well within covenants, though, ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world's first living mitral ...

This story was produced in partnership with the Pulitzer Center. It is part one of a four-part series. Jose Gonzalez* wore no mask, despite the toxic chemicals he worked with in the oil field.

Sigma Planning Corp reduced its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange ...

Embodied carbon reduction strategies helped guide the design of Edwards Lifesciences’ Mussallem Innovation Center, a mix of ...

A local man with heart failure who was told numerous times he only had months to live now has a new outlook on life two years ...

Physicians at the WVU Heart and Vascular Institute (HVI) are the first in the state and region to perform transcatheter ...

Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

Navi Mumbai: With heart valve disease on the rise in India, cardiac experts at Apollo Hospitals Navi Mumbai (AHNM) have highlighted the latest advancements in structural heart disease treatment.

Deciding when to go to the hospital for a rapid heart depends on your health history and how you are feeling overall. A heart rate of 100 beats per minute (bpm) or higher, also known as tachycardia, ...

EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.